Suppr超能文献

激肽释放酶相关肽酶 14 诱导补体 C3a 受体反应。

Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104;

出版信息

J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.

Abstract

Activation of the complement system is primarily initiated by pathogen- and damage-associated molecular patterns on cellular surfaces. However, there is increasing evidence for direct activation of individual complement components by extrinsic proteinases as part of an intricate crosstalk between physiological effector systems. We hypothesized that kallikrein-related peptidases (KLKs), previously known to regulate inflammation via proteinase-activated receptors, can also play a substantial role in innate immune responses via complement. Indeed, KLKs exemplified by KLK14 were efficiently able to cleave C3, the point of convergence of the complement cascade, indicating a potential modulation of C3-mediated functions. By using in vitro fragmentation assays, mass spectrometric analysis, and cell signaling measurements, we pinpointed the generation of the C3a fragment of C3 as a product with potential biological activity released by the proteolytic action of KLK14. Using mice with various complement deficiencies, we demonstrated that the intraplantar administration of KLK14 results in C3-associated paw edema. The edema response was dependent on the presence of the receptor for C3a but was not associated with the receptor for the downstream complement effector C5a. Our findings point to C3 as one of the potential substrates of KLKs during inflammation. Given the wide distribution of the KLKs in tissues and biological fluids where complement components may also be expressed, we suggest that via C3 processing, tissue-localized KLKs can play an extrinsic complement-related role during activation of the innate immune response.

摘要

补体系统的激活主要由细胞表面的病原体和损伤相关的分子模式引发。然而,越来越多的证据表明,某些补体成分可被外在蛋白水解酶直接激活,这是生理效应系统之间复杂串扰的一部分。我们假设,先前已知通过蛋白酶激活受体来调节炎症的激肽释放酶相关肽酶(KLKs)也可以通过补体在先天免疫反应中发挥重要作用。事实上,以 KLK14 为例的 KLKs 能够有效地切割 C3,即补体级联反应的汇聚点,表明 C3 介导的功能可能受到调节。通过使用体外片段化测定、质谱分析和细胞信号测量,我们确定 C3 的 C3a 片段的产生是 KLK14 的蛋白水解作用释放的具有潜在生物学活性的产物。使用具有各种补体缺陷的小鼠,我们证明 KLK14 的皮内给药会导致 C3 相关的爪肿胀。这种水肿反应依赖于 C3a 受体的存在,但与下游补体效应物 C5a 的受体无关。我们的研究结果表明 C3 是炎症过程中 KLKs 的潜在底物之一。鉴于 KLKs 在组织和生物液中的广泛分布,其中也可能表达补体成分,我们认为,通过 C3 加工,组织局部的 KLKs 在先天免疫反应的激活过程中可以发挥外在的补体相关作用。

相似文献

1
Induction of complement C3a receptor responses by kallikrein-related peptidase 14.
J Immunol. 2013 Oct 1;191(7):3858-66. doi: 10.4049/jimmunol.1202999. Epub 2013 Sep 6.
2
Activation of C3a receptor is required in cigarette smoke-mediated emphysema.
Mucosal Immunol. 2015 Jul;8(4):874-85. doi: 10.1038/mi.2014.118. Epub 2014 Dec 3.
3
C3 Drives Inflammatory Skin Carcinogenesis Independently of C5.
J Invest Dermatol. 2021 Feb;141(2):404-414.e6. doi: 10.1016/j.jid.2020.06.025. Epub 2020 Jul 16.
7
10
Complement and : Early Complement-Dependent Events Are Important for DC Migration and Protection During Mouse Lung Infection.
Front Immunol. 2021 Mar 9;12:580594. doi: 10.3389/fimmu.2021.580594. eCollection 2021.

引用本文的文献

2
3
Remodelling of the tumour microenvironment by the kallikrein-related peptidases.
Nat Rev Cancer. 2022 Apr;22(4):223-238. doi: 10.1038/s41568-021-00436-z. Epub 2022 Jan 31.
4
Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation.
Nat Rev Immunol. 2022 Jul;22(7):411-428. doi: 10.1038/s41577-021-00634-8. Epub 2021 Nov 10.
6
Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer.
J Gynecol Oncol. 2020 Nov;31(6):e78. doi: 10.3802/jgo.2020.31.e78.
7
Proteinases and their receptors in inflammatory arthritis: an overview.
Nat Rev Rheumatol. 2018 Mar;14(3):170-180. doi: 10.1038/nrrheum.2018.17. Epub 2018 Feb 8.
8
Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions.
Semin Immunopathol. 2018 Jan;40(1):87-102. doi: 10.1007/s00281-017-0646-9. Epub 2017 Sep 12.
9
Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense.
Immunol Rev. 2016 Nov;274(1):33-58. doi: 10.1111/imr.12500.

本文引用的文献

1
Complement in immune and inflammatory disorders: pathophysiological mechanisms.
J Immunol. 2013 Apr 15;190(8):3831-8. doi: 10.4049/jimmunol.1203487.
4
Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway.
Blood. 2012 Aug 23;120(8):1717-25. doi: 10.1182/blood-2012-02-412080. Epub 2012 Jul 16.
5
Targeting proteinase-activated receptors: therapeutic potential and challenges.
Nat Rev Drug Discov. 2012 Jan 3;11(1):69-86. doi: 10.1038/nrd3615.
6
Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells.
Am J Pathol. 2011 Nov;179(5):2625-36. doi: 10.1016/j.ajpath.2011.07.016. Epub 2011 Sep 9.
7
Complement in skin diseases.
Acta Dermatovenerol Alp Pannonica Adriat. 2011;20(1):3-11.
8
Interactions between coagulation and complement--their role in inflammation.
Semin Immunopathol. 2012 Jan;34(1):151-65. doi: 10.1007/s00281-011-0280-x. Epub 2011 Aug 3.
9
Label-free cell-based assays using photonic crystal optical biosensors.
Analyst. 2011 Mar 21;136(6):1090-102. doi: 10.1039/c0an00899k. Epub 2011 Jan 28.
10
Molecular intercommunication between the complement and coagulation systems.
J Immunol. 2010 Nov 1;185(9):5628-36. doi: 10.4049/jimmunol.0903678. Epub 2010 Sep 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验